FDA Adverse Event Injury Summary report: N

TOTAL TALUS REPLACEMENT

MDR report key: 22957210 · Received September 3, 2025

Report

Report Number
3014833750-2025-00015
Event Type
Injury
Date Received
September 3, 2025
Report Date
September 17, 2025
Manufacturer
RESTOR3D, INC.
Product Code
QNN
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

UPON REVIEW WITH THE PHYSICIAN, THE IMPLANT WAS NOT THE CAUSE OF THE FAILURE. THE PATIENT EXPERIENCED UNEXPECTED CHANGES WITH THEIR ANATOMY IN THE YEARS FOLLOWING TOTAL TALUS REPLACEMENT. OVER TIME, THE ANKLE JOINT BECAME ARTHRITIC, AND CARTILAGE BROKE DOWN LEADING TO ARTHRITIS AND CYSTS IN THE TIBIA, WHICH WAS FURTHER PROGRESSION OF THE ANKLE JOINT DISEASE FOLLOWING TOTAL TALUS REPLACEMENT.

Additional Manufacturer Narrative · 0

IT WAS REPORTED THAT THE PATIENT DEVELOPED ARTHRITIS AND CYSTIC FORMATIONS IN THE ANKLE JOINT 3 YEARS FOLLOWING TOTAL TALUS REPLACEMENT SURGERY. THE DEVICE HAS NOT BEEN RECEIVED BY THE MANUFACTURER FOR EVALUATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT DEVELOPED ARTHRITIS AND CYSTIC FORMATIONS IN THE ANKLE JOINT 3 YEARS FOLLOWING TOTAL TALUS REPLACEMENT SURGERY.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT DEVELOPED ARTHRITIS AND CYSTIC FORMATIONS IN THE ANKLE JOINT 3 YEARS FOLLOWING TOTAL TALUS REPLACEMENT SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2234390 TOTAL TALUS REPLACEMENT TOTAL TALUS REPLACEMENT QNN RESTOR3D, INC. IK3-100LT 20220522-DMP-C-01

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention